Arcturus Therapeutics Holdings INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Arcturus Therapeutics has issued its 2026 proxy statement detailing director elections, executive compensation, and auditor ratification.
NASDAQ
Arcturus Therapeutics announces its 2025 annual stockholders meeting to be held virtually on June 6, 2025, featuring director elections, executive compensation approval, and auditor ratification.
NASDAQ
Arcturus Therapeutics announces its 2024 annual meeting of stockholders to be held virtually on June 14, 2024, featuring proposals including director elections and an amendment to the equity incentive plan.